达维塔保健 DVA 深 沪
等待开盘 02-10 09:30:00 美东时间
137.64
-3.190
-2.27%
华盛通- 最 高141.50
- 今 开140.00
- 成交量 148.83万股
- 最 低 136.19
- 昨 收 140.83
- 总市值 92.01亿
- 52周最高 158.21
- 市盈率 静 13.99
- 换手率 0.00%
- 52周最低 101.00
- 委 比 0.00%
- 总股本 6684.90万
- 历史最高 179.60
- 量 比 0.50
- 振 幅 3.77%
- 历史最低 43.40
- 每 手 1
- 风险率 13.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Berkshire Hathaway's portfolio benefits from Nikkei's post-election bounce
Since 2019, Berkshire Hathaway (BRK.B) (BRK.A) added sizeable stakes of Japan's five major trading houses to its portfolio. That's paying off on Monday as the Nikkei 225 index jumped 5.6% after Prime ...
02-09 21:56
BUZZ-US stocks weekly: Clawed
BUZZ-US stocks weekly: Clawed ** S&P 500 .SPX finishes down 0.1% in rocky trading as new AI automation tool by Anthropic's Claude bruises global markets .N ** Dow .DJI gains 2.5%, ends above 50,000 for the first time ever, while the Nasdaq Composite .IXIC slides 1.8% ** Indeed, traders wondered whet
02-07 05:53
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
美股牛股 | 达维塔保健绩后飙升逾21%！Q4业绩胜市场预期；稀土概念股Critical Metals大涨超20%
达维塔保健绩后飙升逾21%！Q4业绩胜市场预期；稀土概念股CRML大涨超20%，美内政部长称将宣布关键矿产贸易协议；金矿股HYMC隔夜涨超19%，现货黄金重上5000美元关口>>
02-04 15:15
美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
DaVita Earnings Call Signals Cautious Optimism
Davita Healthcare (($DVA)) has held its Q4 earnings call. Read on for the main ...
02-04 08:25
DaVita Stock Rallies On Profit Beat, Confident 2026 View
DaVita stock surged after the kidney care provider beat earnings estimates and issued strong 2026 guidance, signaling stable treatment volumes, higher reimbursement rates, and an improving income outlook.
02-04 01:25
Barclays Maintains Equal-Weight on DaVita, Raises Price Target to $158
Barclays analyst Andrew Mok maintains DaVita (NYSE:DVA) with a Equal-Weight and raises the price target from $143 to $158.
02-03 21:30
BUZZ-U.S. STOCKS ON THE MOVE- Merck & Co, McDonald's, FedEx
BUZZ-U.S. STOCKS ON THE MOVE- Merck & Co, McDonald's, FedEx Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Futures tracking the S&P 500 and the Nasdaq edged higher on Tuesday, stead
02-03 20:18
BUZZ-DaVita rises on upbeat annual profit forecast
BUZZ-DaVita rises on upbeat annual profit forecast ** Dialysis firm DaVita's DVA.N shares rise 10.6% to $121.05 premarket after co forecasts annual profit above estimates ** Co expects 2026 adj. EPS to be between $13.60 and $15 vs analysts' average estimate of $12.65 - LSEG data ** DVA attributes up
02-03 19:48
